Doctor of Philosophy (Ph.D.) Degree Programs
Application Deadline for Fall 2020 Admission: January 10, 2020
To learn about the admissions process, please visit the Ph.D. Programs Admissions page.
"What is Pharmacology?" via YouTube (courtesy of ASPET)
Pharmaceutics is a multidisciplinary science that focuses on the study of the physical, chemical and biological properties of drugs and dosage forms. Cutting across the traditional disciplinary boundaries, pharmaceutics examines the relationship of drug properties to dosage form design, fabrication, evaluation and therapeutic efficacy. Students in the Pharmaceutics program may develop research programs in the areas of drug delivery systems, drug stability, dosage forms and pharmacokinetics.
Pharmacology is the study of the mechanisms of action of drugs and their effects on normal and disease states. It is a science based upon integrating chemistry, biochemistry, cell and molecular biology and physiology. Students in the Pharmacology program may develop research projects in the areas of renal physiology, autonomic and central nervous systems, cardiovascular pharmacology, signal transduction, cellular physiology of exercise and aging, or protein biochemistry.
Students may also study for a concentration in Medicinal Chemistry in the areas of (1) virtual drug screening and design; (2) high throughput screening and drug syntheses; (3) characterization of drug targets and developing of novel therapeutic interventions; or (4) therapeutic natural product screening and identification.
Almost all of our students (international and domestic) are awarded stipends from Research or Teaching Assistantships, and are reimbursed for all tuition and fees. Please see the Financial Aid section for more details.
Visit Admissions page
Download Flier with Course of Study here
Recent Student Publications & Presentations
To view the research and scholarship excellence of UHCOP graduate students:
Recent Publications - click here
Recent Abstracts & Presentations - click here
Recent PPS News
PPS Chronicle Newsletter 2018
UHCOP Team's Work on Novel Compound Targeting Dual Pathways to Stem Pancreatic Cancer Published in Cancer Research Journal
PhD Candidate Gets 3rd ACCP Travel Award for Project Showing Changes in Drug Metabolism After Weight-Loss Surgery
Tam Receives $3.5M in New NIH Funding for Rapid Diagnostic Antimicrobial System
PhD Student, Postdoc Research in Spotlight at PPS Research Symposium
NIH Awards Lokhandwala $2.64M to Study Angiotensin 1-7 for Reducing Hypertension
Researcher Das Targets Brain Receptor as Novel Alcoholism Therapeutic
Hussain Earns $1.6 NIH Grant to Study AT2 Receptor to Protect Obese Kidney
(Adobe Reader required; download latest version here.)